Åsa Ohlsson

667 total citations
18 papers, 407 citations indexed

About

Åsa Ohlsson is a scholar working on Cardiology and Cardiovascular Medicine, Health, Toxicology and Mutagenesis and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Åsa Ohlsson has authored 18 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Health, Toxicology and Mutagenesis and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Åsa Ohlsson's work include Effects and risks of endocrine disrupting chemicals (4 papers), Cardiovascular Conditions and Treatments (4 papers) and Cardiomyopathy and Myosin Studies (3 papers). Åsa Ohlsson is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (4 papers), Cardiovascular Conditions and Treatments (4 papers) and Cardiomyopathy and Myosin Studies (3 papers). Åsa Ohlsson collaborates with scholars based in Sweden, United States and Denmark. Åsa Ohlsson's co-authors include Agneta Oskarsson, Erik Ullerås, Nina Cedergreen, Anna Kjerstine Rosenmai, Johan Lundqvist, Corrado Tringali, Jens Häggström, Björn Hellman, Rikard Tröger and Ingrid Ljungvall and has published in prestigious journals such as Water Research, Scientific Reports and Food and Chemical Toxicology.

In The Last Decade

Åsa Ohlsson

17 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Åsa Ohlsson Sweden 10 139 97 93 72 49 18 407
Lesley Onyon Japan 9 279 2.0× 197 2.0× 85 0.9× 65 0.9× 37 0.8× 9 581
Julie Christoffel Germany 13 207 1.5× 128 1.3× 117 1.3× 41 0.6× 97 2.0× 15 660
Daniele Marcoccia Italy 11 124 0.9× 34 0.4× 59 0.6× 34 0.5× 30 0.6× 24 322
Takeshi Kunimatsu Japan 12 166 1.2× 54 0.6× 218 2.3× 25 0.3× 63 1.3× 23 524
Shaochin Lee China 11 64 0.5× 44 0.5× 113 1.2× 37 0.5× 82 1.7× 14 478
Daniel R. Hallinger United States 12 175 1.3× 105 1.1× 119 1.3× 54 0.8× 129 2.6× 17 548
Normadiah M. Kassim Malaysia 17 145 1.0× 54 0.6× 140 1.5× 23 0.3× 107 2.2× 32 679
Brigitte Gutendorf Germany 3 250 1.8× 140 1.4× 75 0.8× 170 2.4× 20 0.4× 4 462
Juliana Elaine Perobelli Brazil 14 220 1.6× 41 0.4× 89 1.0× 33 0.5× 118 2.4× 40 672
Brett T. Thorn United States 14 208 1.5× 53 0.5× 94 1.0× 38 0.5× 12 0.2× 24 625

Countries citing papers authored by Åsa Ohlsson

Since Specialization
Citations

This map shows the geographic impact of Åsa Ohlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsa Ohlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsa Ohlsson more than expected).

Fields of papers citing papers by Åsa Ohlsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åsa Ohlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsa Ohlsson. The network helps show where Åsa Ohlsson may publish in the future.

Co-authorship network of co-authors of Åsa Ohlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Åsa Ohlsson. A scholar is included among the top collaborators of Åsa Ohlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsa Ohlsson. Åsa Ohlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Qinghong, Åsa Ohlsson, Ingrid Ljungvall, et al.. (2024). Metabolic Abnormalities and Reprogramming in Cats with Naturally Occurring Hypertrophic Cardiomyopathy. ESC Heart Failure. 12(2). 1256–1270.
2.
Abitbol, Marie, Heidi Anderson, Paolo Ferrari, et al.. (2024). Classification of feline hypertrophic cardiomyopathy-associated gene variants according to the American College of Medical Genetics and Genomics guidelines. Frontiers in Veterinary Science. 11. 1327081–1327081. 8 indexed citations
3.
Abitbol, Marie, Heidi Anderson, Jessica J. Hayward, et al.. (2024). Development and validation of animal variant classification guidelines to objectively evaluate genetic variant pathogenicity in domestic animals. Frontiers in Veterinary Science. 11. 1497817–1497817. 5 indexed citations
4.
Ljungvall, Ingrid, Jakob L. Willesen, J. Koch, et al.. (2023). Evaluation of cardiac troponin I as a predictor of death in critically ill cats. Journal of Veterinary Internal Medicine. 37(2). 403–411. 4 indexed citations
5.
Pettersson, Ånna, et al.. (2022). A Questionnaire Survey on Long-Term Outcomes in Cats Breed-Screened for Feline Cardiomyopathy. Animals. 12(20). 2782–2782. 2 indexed citations
6.
Ohlsson, Åsa, M. Longeri, Jessica J. Hayward, et al.. (2022). The TNNT2:c.95‐108G>A variant is common in Maine Coons and shows no association with hypertrophic cardiomyopathy. Animal Genetics. 53(4). 526–529. 6 indexed citations
7.
Wang, Chao, Ola Wallerman, Maja L. Arendt, et al.. (2021). A novel canine reference genome resolves genomic architecture and uncovers transcript complexity. Communications Biology. 4(1). 185–185. 81 indexed citations
8.
Low, Matthew, et al.. (2019). Demography, heritability and genetic correlation of feline hip dysplasia and response to selection in a health screening programme. Scientific Reports. 9(1). 17164–17164. 4 indexed citations
9.
Lundqvist, Johan, Claudia von Brömssen, Anna Kjerstine Rosenmai, et al.. (2019). Assessment of pesticides in surface water samples from Swedish agricultural areas by integrated bioanalysis and chemical analysis. Environmental Sciences Europe. 31(1). 29 indexed citations
10.
Rosenmai, Anna Kjerstine, Johan Lundqvist, Åsa Ohlsson, et al.. (2018). In vitro bioanalysis of drinking water from source to tap. Water Research. 139. 272–280. 45 indexed citations
11.
Oskarsson, Agneta, Erik Ullerås, & Åsa Ohlsson. (2016). Acetaminophen Increases Aldosterone Secretion While Suppressing Cortisol and Androgens: A Possible Link to Increased Risk of Hypertension. American Journal of Hypertension. 29(10). 1158–1164. 7 indexed citations
12.
Oskarsson, Agneta & Åsa Ohlsson. (2016). Suppressed Sex Hormone Biosynthesis by Alkylresorcinols: A Possible Link to Chemoprevention. Nutrition and Cancer. 68(6). 978–987. 12 indexed citations
13.
Oskarsson, Agneta, Carmela Spatafora, Corrado Tringali, & Åsa Ohlsson. (2014). Inhibition of CYP17A1 activity by resveratrol, piceatannol, and synthetic resveratrol analogs. The Prostate. 74(8). 839–851. 25 indexed citations
14.
Ohlsson, Åsa, Erik Ullerås, Nina Cedergreen, & Agneta Oskarsson. (2010). Mixture effects of dietary flavonoids on steroid hormone synthesis in the human adrenocortical H295R cell line. Food and Chemical Toxicology. 48(11). 3194–3200. 22 indexed citations
15.
Ohlsson, Åsa, Nina Cedergreen, Agneta Oskarsson, & Erik Ullerås. (2010). Mixture effects of imidazole fungicides on cortisol and aldosterone secretion in human adrenocortical H295R cells. Toxicology. 275(1-3). 21–28. 50 indexed citations
16.
Ohlsson, Åsa, Erik Ullerås, & Agneta Oskarsson. (2009). A biphasic effect of the fungicide prochloraz on aldosterone, but not cortisol, secretion in human adrenal H295R cells—Underlying mechanisms. Toxicology Letters. 191(2-3). 174–180. 46 indexed citations
17.
Ullerås, Erik, Åsa Ohlsson, & Agneta Oskarsson. (2008). Secretion of cortisol and aldosterone as a vulnerable target for adrenal endocrine disruption — screening of 30 selected chemicals in the human H295R cell model. Journal of Applied Toxicology. 28(8). 1045–1053. 51 indexed citations
18.
Townsley, Mary I., Charlotte Erlanson‐Albertsson, Åsa Ohlsson, Catarina Rippe, & Rolf K. Reed. (1996). Enterostatin efflux in cat intestinal lymph: relation to lymph flow, hyaluronan, and fat absorption. American Journal of Physiology-Gastrointestinal and Liver Physiology. 271(4). G714–G721. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lesley Onyon Breakdown of academic impact, for papers by Julie Christoffel Breakdown of academic impact, for papers by Daniele Marcoccia Breakdown of academic impact, for papers by Takeshi Kunimatsu Breakdown of academic impact, for papers by Shaochin Lee Breakdown of academic impact, for papers by Daniel R. Hallinger Breakdown of academic impact, for papers by Normadiah M. Kassim Breakdown of academic impact, for papers by Brigitte Gutendorf Breakdown of academic impact, for papers by Juliana Elaine Perobelli Breakdown of academic impact, for papers by Brett T. Thorn
Rankless by CCL
2026